furosemide has been researched along with technetium tc 99m medronate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haden, HT; Katz, PG; Konerding, KF | 1 |
Erdmann, WD; Feine, U; Flach, A; Hofmann, U; Müller-Schauenburg, W | 1 |
Bedont, R; Raabe, R; Taylor, A | 1 |
3 other study(ies) available for furosemide and technetium tc 99m medronate
Article | Year |
---|---|
Detection of obstructive uropathy by bone scintigraphy.
Topics: Aged; Aged, 80 and over; Bone and Bones; Furosemide; Humans; Hydronephrosis; Male; Middle Aged; Posture; Radionuclide Imaging; Technetium Tc 99m Medronate; Ureteral Obstruction | 1988 |
Criteria for ureteral obstruction by functional imaging of the upper urinary tract.
Topics: Child; Female; Furosemide; Humans; Iodohippuric Acid; Male; Organometallic Compounds; Pentetic Acid; Radionuclide Imaging; Technetium Tc 99m Medronate; Technetium Tc 99m Pentetate; Ureteral Obstruction | 1987 |
Prolonged half-life following diuretic radionuclide urography as evidence of ureteral obstruction.
Topics: Aged; Furosemide; Half-Life; Humans; Kidney Pelvis; Male; Prostatic Neoplasms; Radionuclide Imaging; Technetium Tc 99m Medronate; Ureteral Obstruction; Urinary Bladder Neoplasms | 1985 |